rs1553579305
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PM1PM2PP2PP3_StrongPP5_Moderate
The NM_001040142.2(SCN2A):c.2645G>A(p.Gly882Glu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_001040142.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 11 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCN2A | ENST00000375437.7 | c.2645G>A | p.Gly882Glu | missense_variant | Exon 16 of 27 | 5 | NM_001040142.2 | ENSP00000364586.2 | ||
SCN2A | ENST00000631182.3 | c.2645G>A | p.Gly882Glu | missense_variant | Exon 16 of 27 | 5 | NM_001371246.1 | ENSP00000486885.1 | ||
SCN2A | ENST00000283256.10 | c.2645G>A | p.Gly882Glu | missense_variant | Exon 16 of 27 | 1 | ENSP00000283256.6 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Complex neurodevelopmental disorder Pathogenic:1Other:1
- -
Submission from Simons Searchlight facilitated by GenomeConnect. Variant interpreted by the Simons Searchlight team most recently on 2016-02-16 and interpreted as Pathogenic. Variant was initially reported on 2014-09-25 by GTR ID of laboratory name 61756. The reporting laboratory might also submit to ClinVar. -
Inborn genetic diseases Pathogenic:1
The c.2645G>A (p.G882E) alteration is located in exon 16 (coding exon 15) of the SCN2A gene. This alteration results from a G to A substitution at nucleotide position 2645, causing the glycine (G) at amino acid position 882 to be replaced by a glutamic acid (E). The alteration is not observed in healthy cohorts:_x000D_ Based on data from the NHLBI Exome Sequencing Project (ESP), the SCN2A c.2645G>A alteration was not observed among 6,502 individuals tested. Allele frequency data for this nucleotide position are not currently available from the 1000 Genomes Project and the alteration is not currently listed in the Database of Single Nucleotide Polymorphisms (dbSNP). The altered nucleotide is conserved throughout evolution:_x000D_ The c.2645G nucleotide is conserved throughout available vertebrate species except the lamprey, which has the nucleotide C at this position._x000D_ The altered amino acid is conserved throughout evolution:_x000D_ The p.G882 amino acid is conserved throughout available vertebrate species, except the opossum and the lamprey. The alteration is predicted deleterious by in silico models:_x000D_ The p.G882E alteration is predicted to be probably damaging by Polyphen and deleterious by SIFT in silico analyses._x000D_ The alteration is predicted not to affect splicing by in silico models:_x000D_ Based on BDGP and ESEfinder splice site in silico tools, this alteration does not have any significant effect on the native acceptor/donor splice site; however, direct evidence is unavailable. Based on the available evidence, this alteration is classified as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at